.png){kind=icon}
.png){kind=icon}
Return
Post hoc estimation of a quantitative restriction spectrum imaging biomarker for prostate cancer detection using conventional MRI
.png){kind=icon}
PRE
AI
DOI：10.1002/acm2.70543.png)
.png){kind=icon}
Original request for help.png){kind=icon}
Share.png){kind=icon}
Save
Abstract
En 中文
Background: Multiparametric MRI is useful for early detection of clinically significant prostate cancer (csPCa), but its standard apparent diffusion coefficient (ADC) has limited utility as a quantitative metric for automated, patient-level detection of csPCa. Restriction spectrum imaging (RSI), an advanced diffusion technique, yields a quantitative biomarker (RSIrs) that improves csPCa detection. RSIrs is typically calculated from a dedicated multi-b-value acquisition. RSIrs estimated from conventional MRI has not been studied. Purpose: To evaluate the accuracy and validity of RSI metrics estimated post hoc from conventional diffusion-weighted imaging (DWI) to serve as a viable surrogate for a dedicated RSI acquisition. Materials and methods: We conducted a retrospective, multicenter study of patients with both a dedicated RSI acquisition and conventional DWI. We compared three different RSI restriction score (RSIrs) calculation methods: from the dedicated acquisition (RSIrs(dedicated)), from conventional DWI alone (RSIrs(post-hoc)), and from a combination of conventional DWI with only the high b-values from the RSI acquisition (RSIrs(combo)). We compared these methods for quantitative agreement and csPCa detection performance (area under the receiver operating characteristic [AUC, 95% confidence interval]) of maximum RSIrs (RSIrs(max)) in the prostate compared to that of minimum ADC (ADC). Results: Data from n = 1095 patients (16 centers) were analyzed. Post hoc RSIrs(max) differed systematically from RSIrs(dedicated) by a median of +156 (RSIrs(post-hoc)) and -59 (RSIrs(combo)), respectively. AUCs for csPCa detection were 0.51 [0.47,0.54], 0.60 [0.57,0.64], 0.70 [0.67,0.74], and 0.77 [0.74,0.80] for ADC, RSIrs(post-hoc), RSIrs(combo), and RSIrs(dedicated), respectively. Conclusion: Even when estimated using conventional DWI, RSIrs is a superior quantitative biomarker to ADC for automated, patient-level detection of csPCa. A dedicated RSI acquisition gives the best performance. A compromise would be to acquire high b-values (1500 and 2500 s/mm(2)) to complement low b-values (<1000 s/mm(2)) from conventional DWI.
Keywords:
diffusion weighted imaging
prostate cancer
radiation therapy
restriction spectrum imaging
Journal
J
IF:
2.2
Papers:
286
Citations:
6.1K
View more organizations